Drugs / Minimally manipulated adipose tissue
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06040957 | Jan 2024 → Jan 2027 expected | osteoarthritis, knee | Rizzoli Orthopaedic Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Minimally manipulated adipose tissue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06040957 ↗ |
| Known as | MM-AT | “The primary objective of the study is to compare the safety and efficacy of a single intra-articular infiltration of Bone marrow aspirate concentrate (BMAC) with one of...” NCT06040957 ↗ |
| Route | Other | “single intra-articular injection of Minimally manipulated adipose tissue derived from the patient's abdominal adipose tissue” NCT06040957 ↗ |